REXN
Rexahn Pharmaceuticals Inc.
Halal Rating :
Last Price
$1.12
Last updated:
Market Cap
-
7D Change
-7.44%
1 Year Change
-59.27%
Company Overview
Exchange
Next Earnings Date
Rexahn Pharmaceuticals Inc. was a clinical-stage biopharmaceutical company dedicated to developing novel treatments for cancer. However, based on the available information, this company appears to have undergone significant changes or may no longer be actively trading under this ticker symbol. The financial data provided shows minimal revenue generation with significant expenses, typical of a pre-revenue biotech company in research and development phase.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $3.87m | $11.88m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $1.11m | $9.44m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $1.71m | $9.42m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Rexahn Pharmaceuticals Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.